Yung Shin Pharm. Ind
Taiwan Updated 9 July 2026
Yung Shin Pharm. Ind is a finished-dose manufacturer based in Taiwan. It appears in 1 regulatory filing across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by EMA. Its most recent recorded inspection, by US FDA, closed on 22 October 2019 as VAI.
2
registered plants
1 with an FDA FEI number
1
filings
across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
6 of 6 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.
Inspection history
- 22 October 2019 VAI US FDA
- 27 July 2018 VAI US FDA
- 8 May 2014 NAI US FDA
- 16 August 2013 NAI US FDA
- 30 April 2012 VAI US FDA
- 5 February 2010 NAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Taiwan, Taiwan | 3002808536 |
| Tachia, Taiwan | Not on file |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| NPRA (MY) | 1 | None |
| EMA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Yung Shin Pharm. Ind comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 22 October 2019.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates